Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes.
about
Estrogens regulate glycosylation of IgG in women and menThe effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.Estrogen and insulin transport through the blood-brain barrierContributions of fat mass and fat distribution to hip bone strength in healthy postmenopausal Chinese women.
P2860
Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estrogen or raloxifene during ...... and cardiometabolic outcomes.
@en
Estrogen or raloxifene during ...... and cardiometabolic outcomes.
@nl
type
label
Estrogen or raloxifene during ...... and cardiometabolic outcomes.
@en
Estrogen or raloxifene during ...... and cardiometabolic outcomes.
@nl
prefLabel
Estrogen or raloxifene during ...... and cardiometabolic outcomes.
@en
Estrogen or raloxifene during ...... and cardiometabolic outcomes.
@nl
P2093
P2860
P356
P1433
P1476
Estrogen or raloxifene during ...... y and cardiometabolic outcomes
@en
P2093
C M Jankowski
J M Kittelson
R S Schwartz
W S Gozansky
P2860
P304
P356
10.1002/OBY.20653
P577
2013-12-06T00:00:00Z